Insider · CIK 0001013421

KUHLA DONALD E

Reports to the SEC for 3 companies · BEDMINSTER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001013421

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-02-07	NPS PHARMACEUTICALS INCA Award	Director	AAward	+15.2K sh	—	—	15,225
2012-01-17	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,278 sh	—	—	136,664
2011-10-17	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,258 sh	—	—	134,386
2011-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,577 sh	—	—	132,128
2011-05-19	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,010 sh	—	—	130,551
2011-04-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,691 sh	—	—	128,541
2011-01-18	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,899 sh	—	—	126,850
2010-10-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,271 sh	—	—	124,951
2010-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,500 sh	—	—	122,680
2010-05-20	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+3,110 sh	—	—	120,180
2010-04-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,512 sh	—	—	117,070
2010-03-16	SYNTHETECH INCM Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$0.37	+$3,330	60,600
2010-03-16	SYNTHETECH INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	$0.37	−$3,330	6,000
2010-01-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,609 sh	—	—	114,558
2009-10-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,189 sh	—	—	109,949
2009-09-23	NPS PHARMACEUTICALS INCStock OptionsA Award	Director	AAward	+36K sh	—	—	36,000
2009-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+3,094 sh	—	—	105,760
2009-05-14	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+5,780 sh	—	—	102,666
2009-04-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,281 sh	—	—	96,886
2009-01-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+3,470 sh	—	—	92,605
2007-10-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+5,457 sh	—	—	61,810
2007-06-29	SYNTHETECH INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$0.37	+$3,700	23,660
2007-06-29	SYNTHETECH INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$0.37	−$3,700	0
2007-06-04	ALBANY MOLECULAR RESEARCH INCA Award	Director	AAward	+1,037 sh	$14.47	+$15K	127,183
2007-06-04	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director	AAward	+1,667 sh	$14.47	+$24.1K	1,667
2007-06-04	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director	AAward	+1,666 sh	$14.47	+$24.1K	3,333
2007-06-04	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director	AAward	+1,667 sh	$14.47	+$24.1K	5,000
2006-06-01	ALBANY MOLECULAR RESEARCH INCA Award	Director	AAward	+964 sh	$10.37	+$9,996.68	125,664
2006-05-12	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,705 sh	—	—	25,946
2006-01-17	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,791 sh	—	—	19,420
2005-11-18	NPS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$8.25	+$24.8K	60,429
2005-11-18	NPS PHARMACEUTICALS INCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2005-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,733 sh	—	—	13,267
2005-06-28	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+10.5K sh	—	—	10,470
2005-05-20	ALBANY MOLECULAR RESEARCH INCM Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	$10.00	+$80K	124,700
2005-05-20	ALBANY MOLECULAR RESEARCH INCS Sale	Director	SSale	−8,000 sh	$11.70	−$93.6K	116,700
2005-05-20	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−8,000 sh	$10.00	−$80K	0
2005-05-18	ALBANY MOLECULAR RESEARCH INCP Purchase	Director	PPurchase	+1,687 sh	$11.85	+$20K	116,700
2005-05-18	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director	AAward	+1,667 sh	$11.85	+$19.8K	1,667
2005-05-18	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director	AAward	+1,666 sh	$11.85	+$19.7K	3,333
2005-05-18	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director	AAward	+1,667 sh	$11.85	+$19.8K	5,000
2005-03-02	ALBANY MOLECULAR RESEARCH INCS Sale	Director	SSale	−15K sh	$10.03	−$150K	101,888
2005-03-01	ALBANY MOLECULAR RESEARCH INCM Exercise/Conversion	Director	MExercise/Conversion	+28.1K sh	$4.44	+$125K	116,888
2005-03-01	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	+28.1K sh	$4.44	+$125K	28,125
2005-02-01	ALBANY MOLECULAR RESEARCH INCM Exercise/Conversion	Director	MExercise/Conversion	+28.1K sh	$4.44	+$125K	103,763
2005-02-01	ALBANY MOLECULAR RESEARCH INCS Sale	Director	SSale	−15K sh	$11.04	−$166K	88,763
2005-02-01	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−28.1K sh	$4.44	−$125K	56,250
2005-01-03	ALBANY MOLECULAR RESEARCH INCM Exercise/Conversion	Director	MExercise/Conversion	+28.1K sh	$11.19	+$315K	90,638
2005-01-03	ALBANY MOLECULAR RESEARCH INCS Sale	Director	SSale	−15K sh	$11.19	−$168K	75,638
2005-01-03	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−28.1K sh	$4.44	−$125K	84,375

Recent filings

Accepted (ET)
Feb 94
NPS PHARMACEUTICALS INC0001474064-12-000024
SEC(opens sec.gov)
Jan 194
NPS PHARMACEUTICALS INC0001474064-12-000006
SEC(opens sec.gov)
Oct 194
NPS PHARMACEUTICALS INC0001474064-11-000046
SEC(opens sec.gov)
Jul 194
NPS PHARMACEUTICALS INC0001474064-11-000027
SEC(opens sec.gov)
May 234
NPS PHARMACEUTICALS INC0001474064-11-000019
SEC(opens sec.gov)
Apr 194
NPS PHARMACEUTICALS INC0001474064-11-000011
SEC(opens sec.gov)
Jan 204
NPS PHARMACEUTICALS INC0001104659-11-002193
SEC(opens sec.gov)
Oct 194
NPS PHARMACEUTICALS INC0001474064-10-000053
SEC(opens sec.gov)
Jul 194
NPS PHARMACEUTICALS INC0001474064-10-000044
SEC(opens sec.gov)
May 244
NPS PHARMACEUTICALS INC0001474064-10-000034
SEC(opens sec.gov)
Apr 194
NPS PHARMACEUTICALS INC0001474064-10-000022
SEC(opens sec.gov)
Mar 174
SYNTHETECH INC0001013421-10-000001
SEC(opens sec.gov)
Jan 194
NPS PHARMACEUTICALS INC0001474064-10-000004
SEC(opens sec.gov)
Oct 164
NPS PHARMACEUTICALS INC0001474064-09-000008
SEC(opens sec.gov)
Sep 254
NPS PHARMACEUTICALS INC0001408617-09-000046
SEC(opens sec.gov)
Jul 174
NPS PHARMACEUTICALS INC0001408617-09-000039
SEC(opens sec.gov)
May 184
NPS PHARMACEUTICALS INC0001408617-09-000030
SEC(opens sec.gov)
Apr 174
KUHLA DONALD E0001408617-09-000023
SEC(opens sec.gov)
Jan 204
KUHLA DONALD E0001408617-09-000005
SEC(opens sec.gov)

Companies

Address

550 HILLS DRIVE

BEDMINSTER, NJ, 07921